Back to LPCN
UBS Group AG LPCN Position History
Lipocine Inc. • Healthcare
Quarters held
9
Latest value
$3K
Q3 2026
Peak value
$45K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $9 |
| Q3 2025 | $5K |
| Q4 2025 | $45K |
| Q1 2026 | $28K |
| Q1 2026 | $64 |
| Q2 2026 | $6K |
| Q2 2026 | $3K |
| Q3 2026 | $5K |
| Q3 2026 | $3K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3K | 1.3K | — | — |
| Q3 2026 | $5K | 2.2K | — | — |
| Q2 2026 | $3K | 1.3K | — | — |
| Q2 2026 | $6K | 2.3K | — | — |
| Q1 2026 | $64 | 8 | — | — |
| Q1 2026 | $28K | 3.5K | — | — |
| Q4 2025 | $45K | 5.6K | — | — |
| Q3 2025 | $5K | 1.8K | — | — |
| Q3 2025 | $9 | 3 | — | — |